Ginkgo Bioworks Holdings Inc Class (DNA)
R&D Expenses
$46.21M
Quarterly · Period ending: · USD
DNA R&D Expenses
Latest reported$46.21Mperiod ending
Latest reported$46.21Mperiod ending
DNA Quarterly R&D Expenses ($30.24M → $46.21M)
Quarterly R&D Expenses
High-resolution chart · PNG
DNA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 46,210,000 | |
| 49,920,000 | |
| 50,127,000 | |
| 69,353,000 | |
| 53,370,000 | |
| 70,923,000 | |
| 76,377,000 | |
| 77,006,000 | |
| 134,221,000 | |
| 136,457,000 | |
| 117,038,000 | |
| 156,662,000 | |
| 144,282,000 | |
| 162,639,000 | |
| 181,155,000 | |
| 261,460,000 | |
| 290,059,000 | |
| 323,576,000 | |
| 985,025,000 | |
| 53,021,000 | |
| 52,031,000 | |
| 59,585,000 | |
| 61,191,000 | |
| 36,070,000 | |
| 32,270,000 | |
| 30,236,000 |